Literature DB >> 33883123

Chronic pain (primary and secondary) in over 16s: summary of NICE guidance.

Serena Carville1, Margaret Constanti2, Nick Kosky3, Cathy Stannard4, Colin Wilkinson5.   

Abstract

Entities:  

Year:  2021        PMID： 33883123     DOI： 10.1136/bmj.n895

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Understanding the Needs and Priorities of People Living with Persistent Pain and Long-Term Musculoskeletal Conditions during the COVID-19 Pandemic-A Public Involvement Project.

Authors:  Sally Fowler Davis; Helen Humphreys; Tom Maden-Wilkinson; Sarah Withers; Anna Lowe; Robert J Copeland
Journal:  Healthcare (Basel)       Date:  2022-06-17

2.  Trusting in the online 'community': An interview study exploring internet use in young people with chronic pain.

Authors:  Anna Hurley-Wallace; Sarah Kirby; Felicity Bishop
Journal:  Br J Pain       Date:  2021-12-27

3.  Massage Therapy: A Person-Centred Approach to Chronic Pain.

Authors:  Richard Lebert; Monica Noy; Eric Purves; Jacqueline Tibbett
Journal:  Int J Ther Massage Bodywork       Date:  2022-09-01

4.  Pain acceptance and illness intrusiveness in low-back pain: A longitudinal study.

Authors:  Eszter Simoncsics; Barna Konkolý Thege; Adrienne Stauder
Journal:  Front Psychiatry       Date:  2022-08-12       Impact factor: 5.435

Review 5.  The Use of Botulinum Toxin A as an Adjunctive Therapy in the Management of Chronic Musculoskeletal Pain: A Systematic Review with Meta-Analysis.

Authors:  Simone Battista; Luca Buzzatti; Marialuisa Gandolfi; Cinzia Finocchi; Luca Falsiroli Maistrello; Antonello Viceconti; Benedetto Giardulli; Marco Testa
Journal:  Toxins (Basel)       Date:  2021-09-10       Impact factor: 4.546

6.  Treating persistent pain after breast cancer: practice gaps and future directions.

Authors:  An De Groef; Mira Meeus; Lauren C Heathcote; Louise Wiles; Mark Catley; Anna Vogelzang; Ian Olver; William B Runciman; Peter Hibbert; Lore Dams; Bart Morlion; G Lorimer Moseley
Journal:  J Cancer Surviv       Date:  2022-03-11       Impact factor: 4.442
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.